PUBLISHER: Grand View Research | PRODUCT CODE: 1363228
PUBLISHER: Grand View Research | PRODUCT CODE: 1363228
The global pediatric catheter market size is expected to reach USD 14.97 billion by 2030, registering a CAGR of 9.3% during the forecast period, according to a new report by Grand View Research, Inc.. Key factors attributing to the growth include increase in the pediatric population, rise in congenital heart defects, neurological disorders, urinary tract infections, and lack of adequate new born screening centers in the emerging countries. The pediatric population requires specially designed catheters with smaller dimensions and advanced materials to avoid hospital acquired infections and improve patient compliance.
In 2022, cardiovascular catheters held the largest market share of 39.9%. The congenital heart defects are one of the major reasons for high mortality in pediatric population. Presence of a wide range of products for various cardiac interventions is key factor boosting the segments growth. Moreover, urology catheters are expected to emerge as the fastest growing segment with a CAGR of 10.0% from 2023 to 2030. High growth is anticipated on account of increasing prevalence of bladder, urethra, uterus, and kidney problems in pediatric population.
North America dominated the pediatric catheters market with the revenue share of 34.4% in 2022. Some of the key factors responsible for the high share are growing prevalence of congenital heart defects and urological problems and rising inpatient and emergency room procedures. Moreover, presence of advanced healthcare facilities, strong reimbursement scenario, and favorable federal initiatives to encourage pediatric device development are anticipated to positively reinforce the growth in this region. Asia Pacific is expected to expand at the fastest CAGR of 11.2% over the forecast period. Developing healthcare infrastructure and increasing healthcare expenditure, along with high unmet medical needs, are expected boost the revenue growth.
Some of the key players operating in this market are Cook Medical; Smiths Medical; Edwards Life Sciences Corporation; Medtronic Inc.; and Johnson & Johnson.